122 related articles for article (PubMed ID: 5058220)
1. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro.
Gutmann HR; Erickson RR
J Biol Chem; 1972 Feb; 247(3):660-6. PubMed ID: 5058220
[No Abstract] [Full Text] [Related]
2. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
Gutmann HR; Erickson RR
J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
[No Abstract] [Full Text] [Related]
3. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
Barry EJ; Malejka-Giganti D; Gutmann HR
Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
[No Abstract] [Full Text] [Related]
4. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
Barry EJ; Gutmann HR
Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
[No Abstract] [Full Text] [Related]
5. N-hydroxy-2-fluorenylacetamide. Reaction of the carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterification.
King CM; Phillips B
J Biol Chem; 1969 Nov; 244(22):6209-16. PubMed ID: 5389104
[No Abstract] [Full Text] [Related]
6. Isolation and identification of the carcinogen N-hydroxy-2-fluorenylacetamide and related compounds by liquid chromatography.
Gutmann HR
Anal Biochem; 1974 Apr; 58(2):469-78. PubMed ID: 4827393
[No Abstract] [Full Text] [Related]
7. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides.
Scribner JD; Miller JA; Miller EC
Cancer Res; 1970 Jun; 30(6):1570-9. PubMed ID: 5457931
[No Abstract] [Full Text] [Related]
8. Oxidation of polycyclic N-arylacetamides to glycolamides and hydroxamic acids in rabbits.
Fries W; Kiese M; Lenk W
Xenobiotica; 1973 Aug; 3(8):525-40. PubMed ID: 4128672
[No Abstract] [Full Text] [Related]
9. Inhibitors of chemical carcinogens as probes for molecular targets: DNA as decisive receptor for metabolite from N-hydroxy-N-2-fluorenylacetamide.
Matsushima T; Weisburger JH
Chem Biol Interact; 1969 Dec; 1(2):211-21. PubMed ID: 5407060
[No Abstract] [Full Text] [Related]
10. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
[No Abstract] [Full Text] [Related]
11. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats.
Weisburger JH; Grantham PH; Horton RE; Weisburger EK
Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633
[No Abstract] [Full Text] [Related]
12. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
[No Abstract] [Full Text] [Related]
13. The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation.
Gutmann HR; Galitski SB; Foley WA
Cancer Res; 1967 Aug; 27(8):1443-55. PubMed ID: 6047873
[No Abstract] [Full Text] [Related]
14. Inhibition of rat liver ribonucleic acid polymerase by the carcinogen N-hydroxy-2-fluorenylacetamide.
Zieve FJ
J Biol Chem; 1972 Sep; 247(18):5987-95. PubMed ID: 5057094
[No Abstract] [Full Text] [Related]
15. Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide.
Grantham PH; Weisburger JH; Weisburger EK
Food Cosmet Toxicol; 1973 Apr; 11(2):209-17. PubMed ID: 4716799
[No Abstract] [Full Text] [Related]
16. Activities of the carcinogen N-hydroxy-2-fluorenylacetamide: insensitivity to cyanide and sulfide of the peroxidase-H202 induced formation of nucleic acid adducts.
King CM; Bednar TW; Linsmaier-Bednar EM
Chem Biol Interact; 1973 Sep; 7(3):185-8. PubMed ID: 4768577
[No Abstract] [Full Text] [Related]
17. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
Zieve FJ; Gutmann HR
Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
[No Abstract] [Full Text] [Related]
18. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
Yost Y; Gutmann HR; Rydell RE
Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
[TBL] [Abstract][Full Text] [Related]
19. Possible role of the glucuronide conjugate in the biochemical mechanism of binding of the carcinogen N-hydroxy-2-acetylaminofluorene to rat-liver deoxyribonucleic acid in vivo.
Irving CC; Veazey RA; Russell LT
Chem Biol Interact; 1969 Oct; 1(1):19-26. PubMed ID: 5407052
[No Abstract] [Full Text] [Related]
20. Structure-activity relationships of N-acylarylhydroxylamines in the rat.
Gutmann HR; Leaf DS; Yost Y; Rydell RE; Chen CC
Cancer Res; 1970 May; 30(5):1485-98. PubMed ID: 4316729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
